Developing new PLGG models replicating such druggable mutation would be highly desired not only to understand the functional role of BRAF V600E mutation in driving PLGG recurrence, but also for future examination of drug resistance as has been noted in melanomas [37]. The gene discussed is BRAF; the disease is melanoma.